NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

MRI Characterization of Mammographically Detected DCIS

Active Not RecruitingN/A

Sponsor: University of Washington

Conditions: Breast Cancer, Stage 0

Interventions: Breast MRI, Laboratory Biomarker Analysis

Countries: United States

This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS). The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical resection can biologically characterize this common pre-invasive malignancy, ductal carcinoma in situ (DCIS), which typically presents in asymptomatic women as suspicious calcifications on mammography.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 80 Years

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* \[Cohort A\] Women aged 18 or older with suspicious calcifications identified on mammography without an associated mass
* \[Cohort B\] Women aged 18 or older with recent biopsy-proven DCIS with residual calcifications present on mammogram after biopsy

Exclusion Criteria for Both Cohorts:

* Patients with prior history of breast cancer in the ipsilateral breast
* Patients with a newly diagnosed breast cancer in the contralateral breast
* Contra-indication to contrast-enhanced breast MRI (e.g. renal insufficiency with GFR\<60, contrast allergy, incompatible metal)
* Patients who currently are undergoing chemoprevention therapy (e.g. aromatase inhibitors or selective estrogen receptor modulators)
* Women who are pregnant

Locations (1)

Seattle, Washington, United States